ロード中...
Biologic Drugs for Rheumatoid Arthritis in the Context of Biosimilars, Genetics, Epigenetics and COVID-19 Treatment
Rheumatoid arthritis (RA) affects around 1.2% of the adult population. RA is one of the main reasons for work disability and premature retirement, thus substantially increasing social and economic burden. Biological disease-modifying antirheumatic drugs (bDMARDs) were shown to be an effective therap...
保存先:
| 出版年: | Cells |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7914976/ https://ncbi.nlm.nih.gov/pubmed/33557301 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells10020323 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|